Login Register Cart 0

Articles by Disease (Melanoma)

Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1707-1712
Author(s): Ramin Altaha, Tito Fojo, Eddie Reed and Jame Abraham

Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1723-1734
Author(s): Shazib Pervaiz

Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1765-1780
Author(s): Eric J. Friedman

Tropism-Modified Adenoviral and Adeno-Associated Viral Vectors for Gene Therapy

Journal: Current Gene Therapy
Volume: 2
Page: 273-293
Author(s): Stuart A. Nicklin and Andrew H. Baker

Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.

Journal: Current Gene Therapy
Volume: 2
Page: 307-322
Author(s): Ingrid J. van Dillen, Nanno H. Mulder, Willem Vaalburg, Erik F.J. de Vries and Geke A.P. Hospers

Transductional Targeting with Recombinant Adenovirus Vectors

Journal: Current Gene Therapy
Volume: 2
Page: 323-339
Author(s): Valerie Legrand, Philippe Leissner, Arend Winter, Majid Mehtali and Monika Lusky

Polycistronic Viral Vectors

Journal: Current Gene Therapy
Volume: 2
Page: 355-378
Author(s): P. de Felipe

Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors

Journal: Current Gene Therapy
Volume: 2
Page: 379-392
Author(s): O. Mazda

Engineering Antibodies for Therapy

Journal: Current Pharmaceutical Biotechnology
Volume: 3
Page: 237-256
Author(s): Leonard G. Presta

Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress

Journal: Current Pharmaceutical Biotechnology
Volume: 3
Page: 275-283
Author(s): Patrice Decker and Sylviane Muller


© 2024 Bentham Science Publishers | Privacy Policy